Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US.
Level 5 - mechanism / opinion, no new human data
Bench analytical chemistry testing of consumer products without human participants (by design analogy, not clinical CEBM)
PubMed 37097362 · doi:10.1001/jama.2023.2296
What was done
The study analyzed products marketed and sold in the United States as melatonin gummies to measure the actual quantities of melatonin and cannabidiol (CBD) compared with the quantities declared on their labels.
What was found
The abstract reports no numbers, percentages, or directional findings regarding how measured amounts compared to labeled amounts.
Why it matters
Accurate quantification of active ingredients in over-the-counter gummies is relevant for consumer safety and assessing label fidelity.
Limits
The abstract provides no sample size, testing methods, brand information, or quantitative outcomes. As a product assay, it did not measure clinical efficacy, bioavailability, or human health outcomes.
Cited by
- contradicts Some over-the-counter vitamin D3 and melatonin supplements have been found to contain 1,000 to 10,000 times more active ingredient than stated on the label.